Nong Xu

2.1k total citations
90 papers, 1.1k citations indexed

About

Nong Xu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Nong Xu has authored 90 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Oncology, 46 papers in Pulmonary and Respiratory Medicine and 18 papers in Surgery. Recurrent topics in Nong Xu's work include Gastric Cancer Management and Outcomes (24 papers), Lung Cancer Treatments and Mutations (21 papers) and Colorectal Cancer Treatments and Studies (19 papers). Nong Xu is often cited by papers focused on Gastric Cancer Management and Outcomes (24 papers), Lung Cancer Treatments and Mutations (21 papers) and Colorectal Cancer Treatments and Studies (19 papers). Nong Xu collaborates with scholars based in China, United States and Canada. Nong Xu's co-authors include Weijia Fang, Yulong Zheng, Lisong Teng, Chenyu Mao, Wojciech Dawicki, Dunia Jawdat, Jean S. Marshall, Yongfeng Ding, Peng Zhao and Haibo Mou and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Nong Xu

85 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nong Xu China 18 506 425 289 195 161 90 1.1k
Pingping Hu China 17 422 0.8× 256 0.6× 294 1.0× 117 0.6× 128 0.8× 65 1.1k
Agnès François France 25 374 0.7× 385 0.9× 422 1.5× 257 1.3× 161 1.0× 55 1.6k
Feng Zhan China 18 318 0.6× 281 0.7× 422 1.5× 146 0.7× 114 0.7× 68 1.0k
Yi‐Wei Xu China 20 269 0.5× 218 0.5× 480 1.7× 352 1.8× 203 1.3× 97 1.2k
Liang Zhu China 18 239 0.5× 136 0.3× 350 1.2× 225 1.2× 69 0.4× 52 942
Sunhoo Park South Korea 22 498 1.0× 453 1.1× 433 1.5× 195 1.0× 73 0.5× 77 1.4k
Nan Jia China 22 209 0.4× 193 0.5× 592 2.0× 185 0.9× 109 0.7× 78 1.5k
Yuanyu Wang China 24 284 0.6× 208 0.5× 695 2.4× 157 0.8× 123 0.8× 64 1.3k
Yuki Kiyozumi Japan 19 542 1.1× 354 0.8× 258 0.9× 462 2.4× 166 1.0× 45 1.2k

Countries citing papers authored by Nong Xu

Since Specialization
Citations

This map shows the geographic impact of Nong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nong Xu more than expected).

Fields of papers citing papers by Nong Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nong Xu. The network helps show where Nong Xu may publish in the future.

Co-authorship network of co-authors of Nong Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Nong Xu. A scholar is included among the top collaborators of Nong Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nong Xu. Nong Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Wenfeng, Jinhua Luo, Nong Xu, et al.. (2025). PARP (Poly ADP‐ribose Polymerase) Family in Health and Disease. MedComm. 6(9). e70314–e70314. 2 indexed citations
2.
Li, Wenfeng, et al.. (2025). Artificial intelligence in radiobiology: Bridging mechanisms and data analysis. SHILAP Revista de lepidopterología. 6(6). 301–311.
3.
Wang, Qing, Nong Xu, Qiao Liu, et al.. (2024). Pervaporation Dehydration Mechanism and Performance of High-Aluminum ZSM-5 Zeolite Membranes for Organic Solvents. International Journal of Molecular Sciences. 25(14). 7723–7723. 2 indexed citations
4.
Li, Ning, et al.. (2024). A retrospective study of adjuvant albumin-bound paclitaxel plus S-1 after D2 gastrectomy versus oxaliplatin plus S-1 in gastric cancer. Scientific Reports. 14(1). 15150–15150. 1 indexed citations
5.
Ding, Yongfeng, Xiaolu Ma, Xiaoyu Chen, et al.. (2023). The Memorial Sloan Kettering Prognostic Score: Correlation with survival in patients with advanced gastric cancer. Cancer Medicine. 12(19). 19656–19666. 2 indexed citations
6.
7.
Mao, Chenyu, Yongfeng Ding, & Nong Xu. (2021). Semen as a rich source of diagnostic biomarkers for prostate cancer: latest evidence and implications. Molecular and Cellular Biochemistry. 477(1). 213–223.
8.
Wu, Mengjie, Yongfeng Ding, Xiaoxia Jiang, et al.. (2020). Overexpressed MAGP1 Is Associated With a Poor Prognosis and Promotes Cell Migration and Invasion in Gastric Cancer. Frontiers in Oncology. 9. 1544–1544. 5 indexed citations
9.
Zheng, Yulong, Yongfeng Ding, Qifeng Wang, et al.. (2019). 90-gene signature assay for tissue origin diagnosis of brain metastases. Journal of Translational Medicine. 17(1). 331–331. 12 indexed citations
10.
Xu, Rui‐Hua, Fenggong Wang, Fanchao Feng, et al.. (2018). Recombinant humanized anti-PD-1 monoclonal antibody (JS001) in patients with refractory/metastatic nasopharyngeal carcinoma: Preliminary results of an open-label phase II clinical study. Annals of Oncology. 29. viii409–viii409. 5 indexed citations
11.
Wang, Zhiqiang, Dong-sheng Zhang, Nong Xu, et al.. (2016). Phase II study of oxaliplatin combined with S-1 and leucovorin (SOL) for Chinese patients with metastatic colorectal cancer. Chinese Journal of Cancer. 35(1). 8–8. 2 indexed citations
12.
Sun, Yuanjue, Yongqian Shu, Baorui Liu, et al.. (2016). A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy. Experimental and Therapeutic Medicine. 12(6). 4017–4024. 19 indexed citations
13.
Li, Longyun, Wei Zhong, Meilin Liao, et al.. (2012). [A study on the long-term non-small cell lung cancer survivors in the Expand Access Program of gefitinib in China].. SHILAP Revista de lepidopterología. 15(6). 332–9. 5 indexed citations
14.
Chen, Jian, et al.. (2012). RRM1 and ERCC1 expression in peripheral blood versus tumor tissue in gemcitabine/carboplatin-treated advanced non-small cell lung cancer. Cancer Chemotherapy and Pharmacology. 69(5). 1277–1287. 26 indexed citations
15.
Mou, Haibo, Yi Zheng, Peng Zhao, et al.. (2011). Celastrol induces apoptosis in non-small-cell lung cancer A549 cells through activation of mitochondria- and Fas/FasL-mediated pathways. Toxicology in Vitro. 25(5). 1027–1032. 85 indexed citations
16.
Zhao, Qiong, Jianzhong Shentu, Nong Xu, et al.. (2010). Phase I study of icotinib hydrochloride (BPI-2009H), an oral EGFR tyrosine kinase inhibitor, in patients with advanced NSCLC and other solid tumors. Lung Cancer. 73(2). 195–202. 81 indexed citations
17.
Dawicki, Wojciech, Dunia Jawdat, Nong Xu, & Jean S. Marshall. (2010). Mast Cells, Histamine, and IL-6 Regulate the Selective Influx of Dendritic Cell Subsets into an Inflamed Lymph Node. The Journal of Immunology. 184(4). 2116–2123. 81 indexed citations
18.
Xu, Nong, et al.. (2007). Phase II study of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer. Cancer Chemotherapy and Pharmacology. 60(4). 601–607. 7 indexed citations
19.
20.
Xu, Nong, Peng Shen, Hanying Bao, et al.. (2006). Phase II trial of a 2-h infusion of gemcitabine plus carboplatin as first-line chemotherapy for advanced non-small-cell lung cancer. Cancer Chemotherapy and Pharmacology. 59(1). 1–7. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pingping Hu Breakdown of academic impact, for papers by Agnès François Breakdown of academic impact, for papers by Feng Zhan Breakdown of academic impact, for papers by Yi‐Wei Xu Breakdown of academic impact, for papers by Liang Zhu Breakdown of academic impact, for papers by Sunhoo Park Breakdown of academic impact, for papers by Nan Jia Breakdown of academic impact, for papers by Yuanyu Wang Breakdown of academic impact, for papers by Yuki Kiyozumi
Rankless by CCL
2026